US Customers: This item requires a permit. Click here for more information
Product Description
Monoclonal antibody of 100 µL targeting SynCAM (TSLC1/CADM1) for FCM and IP.| Product Specifications | |
| Application | FC, IP | 
| Reactivity | Human, Rat | 
| Clonality | Monoclonal IgY | 
| Host | Chicken | 
| Immunogen | Recombinant Fc fusion SynCAM | 
| Gene ID - Human | |
| Formulation | 1 mg/mL in PBS/1% BSA/0.09% NaN3 | 
| Storage | |
| Documents & Links for Anti-SynCAM (TSLC1/CADM1) mAb-Biotin (Clone: 3E1) | |
| Datasheet | Anti-SynCAM (TSLC1/CADM1) mAb-Biotin (Clone: 3E1) Datasheet | 
| Documents & Links for Anti-SynCAM (TSLC1/CADM1) mAb-Biotin (Clone: 3E1) | |
| Datasheet | Anti-SynCAM (TSLC1/CADM1) mAb-Biotin (Clone: 3E1) Datasheet | 
| Citations for Anti-SynCAM (TSLC1/CADM1) mAb-Biotin (Clone: 3E1) – 4 Found | 
| Rademacher, Nils; Schmerl, Bettina; Lardong, Jennifer A; Wahl, Markus C; Shoichet, Sarah A. MPP2 is a postsynaptic MAGUK scaffold protein that links SynCAM1 cell adhesion molecules to core components of the postsynaptic density. Scientific Reports. 2016;6:35283.  PubMed - Comments: Used in: IP  | 
| Balan, Sreekumar; Arnold-Schrauf, Catharina; Abbas, Abdenour; Couespel, Norbert; Savoret, Juliette; Imperatore, Francesco; Villani, Alexandra-Chloé; Vu Manh, Thien-Phong; Bhardwaj, Nina; Dalod, Marc. Large-Scale Human Dendritic Cell Differentiation Revealing Notch-Dependent Lineage Bifurcation and Heterogeneity. Cell Reports. 2018;24(7):1902-1915.e6.  PubMed - Comments: Used in: FCM  | 
| Cañete, Pablo F; Sweet, Rebecca A; Gonzalez-Figueroa, Paula; Papa, Ilenia; Ohkura, Naganari; Bolton, Holly; Roco, Jonathan A; Cuenca, Marta; Bassett, Katharine J; Sayin, Ismail; Barry, Emma; Lopez, Angel; Canaday, David H; Meyer-Hermann, Michael; Doglioni, Claudio; Fazekas de St Groth, Barbara; Sakaguchi, Shimon; Cook, Matthew C; Vinuesa, Carola G. Regulatory roles of IL-10-producing human follicular T cells. The Journal Of Experimental Medicine. 2019;216(8):1843-1856.  PubMed - Comments: Used in: FCM  | 
| Makiyama, Junya; Kobayashi, Seiichiro; Watanabe, Eri; Ishigaki, Tomohiro; Kawamata, Toyotaka; Nakashima, Makoto; Yamagishi, Makoto; Nakano, Kazumi; Tojo, Arinobu; Watanabe, Toshiki; Uchimaru, Kaoru. CD4(+) CADM1(+) cell percentage predicts disease progression in HTLV-1 carriers and indolent adult T-cell leukemia/lymphoma. Cancer Science. 2019;110(12):3746-3753.  PubMed - Comments: Used in: FCM  |